PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Electra Therapeutics, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Electra Therapeutics, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

Cash quality

Profit Cash Ratio

—

Data incomplete

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

—

Data incomplete

Growth Efficiency Ratio

—

Data incomplete

Asset Productivity Ratio

—

Data incomplete

Balance-sheet strength

Debt Due Cover Ratio

-100.0×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 83% of Healthcare companies in United States.

Cash Cushion Ratio

+15%

Cash, after subtracting all debt, equals 15% of its market value (net cash).

Higher than 57% of Healthcare companies in United States.

Tangible Assets Ratio

—

Data incomplete

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

—

Data incomplete

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (9)

Electra Therapeutics, Inc. made a loss over the last year. Electra Therapeutics, Inc. owes $1.25 for every $1 it owns. Electra Therapeutics, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Electra Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

-21.69

Electra Therapeutics, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.

Market cap

$581 M

The total market value of all of Electra Therapeutics, Inc.'s shares at today's price (share price × number of shares), larger than 57% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Net worth (book value)

Negative

Electra Therapeutics, Inc.'s net worth is negative ($27 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.

Owes vs Owns

1.25×

Electra Therapeutics, Inc. owes $1.25 for every $1 it owns, so it owes more than it owns, higher than 92% of Healthcare companies in United States.

Dividend yield

None

Electra Therapeutics, Inc. does not currently pay a dividend.

Profit growth

Loss

Electra Therapeutics, Inc. made a loss in each of the last two years.

Interest cover

Not covered

Electra Therapeutics, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net cash

Electra Therapeutics, Inc. held $84 M more cash than debt (net cash) at Dec 2025.

Questions

How much does Electra Therapeutics, Inc. owe compared with what it owns?

Electra Therapeutics, Inc. owes $1.25 for every $1 it owns, so it owes more than it owns, higher than 92% of Healthcare companies in United States.

Does Electra Therapeutics, Inc. pay a dividend?

No. Electra Therapeutics, Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.